Blog
RSS FeedPosted by Michael Wonder on 24 Nov 2016
USA’s BIO slams Japan’s pharma reimbursement and pricing system
23 November 2016 - The US trade group the Biotechnology Innovation Organization, has declared its disappointment in Japan's price modification ...
Posted by Michael Wonder on 21 Nov 2016
Regeneron CEO: A few ‘bad actors’ are raising drug prices for no reason
19 November 2016 - At an EY forum on Friday, the CEO of Regeneron Pharmaceuticals acknowledged that “really bad actors” ...
Posted by Michael Wonder on 21 Nov 2016
Pfizer sues Texas health agency for releasing confidential pricing information
18 November 2016 - Pfizer has sued Texas' health agency, claiming it violated state and federal law by releasing the ...
Posted by Michael Wonder on 16 Nov 2016
How drug price pressure helped sink Novo's insulin pill
16 November 2016 - Commercial rather than technical hurdles ultimately torpedoed Novo Nordisk's bid to make an oral form of ...
Posted by Michael Wonder on 16 Nov 2016
How to make drug prices fair to U.S. consumers
16 November 2016 - Americans pay far more for branded prescription drugs than people in any other developed nation, exactly ...
Posted by Michael Wonder on 16 Nov 2016
Trump used to rail against drug prices. Now the industry's allies are helping shape his agenda
15 November 2016 - President-elect Donald Trump made the cost of prescription drugs a central part of his healthcare pitch while ...
Posted by Michael Wonder on 16 Nov 2016
AMA embraces value-based drug pricing
15 November 2016 - The US' largest physician organisation is supporting value-based pricing for medications. ...
Posted by Michael Wonder on 14 Nov 2016
Pharma's not off the hook for high drug prices
15 November 2016 - Drug makers and insurers hold talks to come up with solutions. ...
Posted by Michael Wonder on 13 Nov 2016
HHS watchdog office steps up focus on drug pricing
10 November 2016 - Seeking to address rising concerns about prescription medicines, the watchdog arm of the US Department of ...
Posted by Michael Wonder on 02 Nov 2016
California’s Proposition 61: will direct democracy impact prescription-drug pricing?
1 November 2016 - Even in this unconventional election season, California politics has generated little national interest. ...
Posted by Michael Wonder on 02 Nov 2016
Give and take: US pharma & payers forge risk-sharing deals for new heart drugs
1 November 2016 - U.S. commercial payers and pharmaceutical companies have rarely engaged in outcomes-based risk-sharing arrangements, at least until ...
Posted by Michael Wonder on 02 Nov 2016
Sanders takes aim at insulin makers in latest price attack
1 November 2016 - Eli Lilly shares briefly drop after tweet by senator. ...
Posted by Michael Wonder on 28 Oct 2016
Drug prices, not the health law, top voters’ health priorities for 2017
27 October 2016 - Until this week, when big increases in insurance premiums were unveiled for next year, the federal ...
Posted by Michael Wonder on 28 Oct 2016
In Washington’s drug price fight, plenty of blame to go around
27 October 2016 - Drug price legislation could be attached to FDA bill next year. ...
Posted by Michael Wonder on 26 Oct 2016
Crunch time for Obamacare
26 October 2016 - Big rises in premiums will cause most pain away from the exchanges. ...